Patient Outcomes

Early Stem Cell Infusion After First Heart Attack Cuts Heart Failure Risk in Phase 3 Trial

The BMJ trial in Iran tested early intracoronary infusions of umbilical cord–derived mesenchymal cells as an add‑on to standard post‑MI care.